Venous thrombosis in immunocompetent patients with acute cytomegalovirus infection: A complication that may be underestimated

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 851-854

  Abgueguen, P ^a   Delbos, V ^b   Ducancelle, A ^c   Jomaa, S ^a   Fanello, S ^d   Pichard, E ^a  

^a Service de médecine interne maladies infectieuses   (France)

^b Unité de Prévention et de Lutte contre les Infections Nosocomiales   (France)

^c Lab de Bacteriol Virologie Hygiene   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Complications; Cytomegalovirus infection; Immunocompetent patient; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; GANCICLOVIR; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASTHENIA; CHILL; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; HEADACHE; HOSPITAL PATIENT; HUMAN; IMMUNOCOMPETENCE; LUNG EMBOLISM; MALE; MENINGITIS; MONONUCLEOSIS; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; ULCERATIVE COLITIS; VEIN THROMBOSIS;

CYTOMEGALOVIRUS;

EID: 77954650574     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03022.x     Document Type: Article

References (15)

1. Carlström G. Virologic studies on cytomegalovirus inclusion disease. Acta Paediatr Scand 1965, 54:17-23.
2. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006, 43:1143-1151.
3. Wreghitt TG, Teare EL, Sule O, Devi R, Rice P. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 2003, 37:1603-1606.
4. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Matthew E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008, 5:47.
5. Abgueguen P, Delbos V, Chennebault JM, Payan C, Pichard E. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 2003, 36:E134-E139.
6. Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA. Lessons from the natural history of cytomegalovirus. AIDS 1996, 10(suppl 1):S37-S41.
7. Busca A. Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation: significant progress, but many unresolved problems. Expert Opin Biol Ther 2009, 9:383-385.
8. Horwitz CA, Henle W, Henle G. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 1986, 65:124-134.
9. Ragnaud JM, Morlat P, Gin H. Clinical, biological and developmental aspects of cytomegalovirus infection in immunocompetent patients: apropos of 34 hospitalized patients. Rev Med Interne 1994, 15:13-18.
10. Faucher JF, Abraham B, Segondy M, Jonquet O, Reynes J, Janbon F. Acquired cytomegalovirus infections in immunocompetent adults: 116 cases. Presse Med 1998, 27:1774-1779.
11. Bonnet F, Neau D, Viallard JF. Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults. Ann Med Int 2001, 152:227-235.
12. Squizzato A, Gerdes VE, Buller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 2005, 93:403-410.
13. Speir E, Modali R, Huang ES. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994, 265:391-394.
14. Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007, 9:212-218.
15. Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 2007, 54:47-50.